Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), M.C.P.S (Medicine)
Internal Medicine Specialist
MBBS(Gold Medalist), FCPS (Medicine)
Gastroenterologist
M.B.B.S., F.C.P.S., F.C.P.S.
Consultant Physician
M.B.B.S., FCPS (Medicine), FCPS (Pulmonology), FRCP
Consultant Physician
M.B.B.S., FCPS (Medicine), FCPS (Pulmonology), FRCP
Internal Medicine Specialist
F.C.P.S. (Medicine), M.B.B.S
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Internal Medicine Specialist
MBBS (AIMC), MD (USA), FACP (US), Diplomat American Board of Internal Medicine, Diplomat American Board of Geriatric Medicine
Internal Medicine Specialist
MBBS (AIMC), MD (USA), FACP (US), Diplomat American Board of Internal Medicine, Diplomat American Board of Geriatric Medicine
Internal Medicine Specialist
MBBS, FCPS Medicine (Pak), MACP (USA), Dip Aero-Space Medicine , Consultant in Internal Medicine , Special interest in Diabetology, Endocrinology & Rheumatology.
Internal Medicine Specialist
MBBS, FCPS Medicine (Pak), MACP (USA), Dip Aero-Space Medicine , Consultant in Internal Medicine , Special interest in Diabetology, Endocrinology & Rheumatology.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures